Literature DB >> 7077357

Increased collagen synthesis by Duchenne myogenic clones.

V Ionasescu, R Ionasescu.   

Abstract

Myogenic cell clones were grown in triplicates from 3 patients with Duchenne muscular dystrophy, 5 with late onset myotonic dystrophy, 2 with spinal muscular atrophy, 6 male children controls, 4 adult controls and 6 normal aborted fetuses (10-12 weeks old). The clones from patients with myotonic dystrophy and spinal muscular atrophy had normal collagen synthesis. The fetal clones showed 3.3-fold lower values than control clones for [3H] extracellular (medium) hydroxyproline, while intracellular [3H] hydroxyproline levels showed normal values. Analysis of [3H] proline incorporation demonstrated a 4-fold increase in [3H] hydroxyproline released into the medium of Duchenne myogenic cell clones while intracellular [3H] hydroxyproline levels showed normal values. The collagen turnover of Duchenne clones was normal. These results strongly suggest that the increased amount of collagen present in Duchenne dystrophic muscle is related to the primary defect of the disease and is not due to secondary replacement fibrosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7077357     DOI: 10.1016/0022-510x(82)90220-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway.

Authors:  K M Graham; R Singh; G Millman; G Malnassy; F Gatti; K Bruemmer; C Stefanski; H Curtis; J Sesti; C G Carlson
Journal:  J Neurol Sci       Date:  2010-05-13       Impact factor: 3.181

2.  Amniocyte collagen synthesis does not distinguish Duchenne muscular dystrophy.

Authors:  R Stern; J Hall; M S Golbus
Journal:  Am J Hum Genet       Date:  1984-11       Impact factor: 11.025

3.  A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice.

Authors:  Stefano Biressi; Elen H Miyabara; Suchitra D Gopinath; Poppy M M Carlig; Thomas A Rando
Journal:  Sci Transl Med       Date:  2014-12-17       Impact factor: 17.956

4.  Regenerative capacity of mdx mouse muscles after repeated applications of myo-necrotic bupivacaine.

Authors:  Y Itagaki; K Saida; K Iwamura
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

5.  Targeting Muscle-Resident Single Cells Through in vivo Electro-Enhanced Plasmid Transfer in Healthy and Compromised Skeletal Muscle.

Authors:  Francesca Florio; Silvia Accordini; Michela Libergoli; Stefano Biressi
Journal:  Front Physiol       Date:  2022-04-01       Impact factor: 4.755

Review 6.  Pirfenidone as a novel cardiac protective treatment.

Authors:  Alberto Aimo; Giosafat Spitaleri; Giorgia Panichella; Josep Lupón; Michele Emdin; Antoni Bayes-Genis
Journal:  Heart Fail Rev       Date:  2021-10-20       Impact factor: 4.214

Review 7.  Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond.

Authors:  Alberto Aimo; Giosafat Spitaleri; Dario Nieri; Laura Maria Tavanti; Claudia Meschi; Giorgia Panichella; Josep Lupón; Francesco Pistelli; Laura Carrozzi; Antoni Bayes-Genis; Michele Emdin
Journal:  Card Fail Rev       Date:  2022-04-14

8.  The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and Mice.

Authors:  Rylie M Hightower; Andrea L Reid; Devin E Gibbs; Yimin Wang; Jeffrey J Widrick; Louis M Kunkel; Jenna M Kastenschmidt; S Armando Villalta; Thomas van Groen; Hua Chang; Savanna Gornisiewicz; Yosef Landesman; Sharon Tamir; Matthew S Alexander
Journal:  Mol Ther       Date:  2019-09-03       Impact factor: 11.454

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.